Inhalopédia | Inhalers

Class
- Short-acting muscarinic antagonist (SAMA)
  Short-acting beta-2 agonist (SABA)
Active ingredient
- Ipratropium bromide
- Salbutamol (as sulfate)
Device
- Respimat®
Inhalers techniques and maintenance
Age
- 18 +
Typical use
- Asthma
  no common use
Asthma management principles
- COPD
  no common use
COPD management principles
Marketed strength
- 20/100 mcg
Number of doses
- 120 doses
Dose indicator
- Yes | Indicator
Usual adult dosage
- 1 inh QID + PRN
  Maximum daily dose: 6 inh
Usual pediatric dosage
- -
Required inspiratory flow
- < 30 L/min
  Zero internal resistance (R0)
Inspiratory flows
Public coverage
- All provinces expect AB – ON – QC | Open/Regular Benefit
  AB – ON – QC | Not a Benefit
Advantages
- Suitable for low inspiratory flows
- Impossible to take empty (locking mechanism)
- Can be used with a spacer
Disadvantages
- Short duration of action
- Cartridge insertion difficult
- Base turn for loading difficult
- Risk of spraying the face if cap opened before rotating the base
- Occasional cough without spacer
- Synchronism required
Side effects

Product monograph

Download

Combivent®